AstraZeneca bid for drug not curing its ailing stock...
AstraZeneca bid for drug not curing its ailing stock
AstraZeneca Plc, which has operations in Westboro, is entering a final phase in an unprecedented research program to prove its Crestor cholesterol pill is better than Pfizer Inc.'s Lipitor. The risk of failure is weighing down the U.K. drugmaker's ailing stock.
The test, to be completed in 2011, is designed to prove that Crestor...
Submitted by admin on Fri, 2008-04-18 08:40.